2026 Evidence Snapshot: Non‑Thermal RF Bioeffects Across 6 GHz, 3.5 GHz, 2.45 GHz, and 28 GHz—Why Heat‑Only Safety Limits Don’t Track Biology
Research
Effect Synthesis
Mar 1, 2026
Synthesis of 13 studies (2026) spanning 6 GHz, 3.5 GHz, 2.45 GHz Wi‑Fi, 28 GHz mmWave, and real‑world base‑station proximity and smartphone use. Across mechanistic, animal, and observational evidence, multiple biologi…
2026 EMF Research Snapshot: Non‑Thermal Biological Effects Across 6 GHz, 3.5 GHz, 2.45 GHz Wi‑Fi, and 28 GHz mmWave—Why Thermal‑Only Safety Limits Are Not Enough
Research
Effect Synthesis
Mar 1, 2026
Synthesis of 12 studies (2026) linking RF/EMF exposures and wireless tech use to oxidative stress, apoptosis, reproductive harm, kidney changes, sleep disruption, and base-station symptom patterns—supporting precautio…
Doxorubicin-induced cardiotoxicity under 28 GHz 5G-band electromagnetic radiation in rats: Insights into the mitigative role of vitamin C
Research
RF Safe Research Library
Jan 1, 2026
This animal study tested whether short-term 28 GHz (5G-band) millimeter-wave exposure modifies doxorubicin-induced cardiotoxicity in male rats and whether vitamin C mitigates effects. Co-exposure to 28 GHz EMR was reported to worsen several indices of DOX-related cardiac injury (including CAT reduction, increased BAX…
Synergistic cytotoxic effects of an extremely low-frequency electromagnetic field with doxorubicin on MCF-7 cell line.
Research
RF Safe Research Library
Jan 1, 2023
This in vitro study tested whether a 50 Hz, 20 mT extremely low-frequency electromagnetic field (ELF-EMF) enhances the cytotoxic effects of doxorubicin (DOX) in the MCF-7 breast cancer cell line. The authors report that combining ELF-EMF with low-dose DOX reduced cell viability at lower DOX concentrations than DOX…
Effects induced by a 50 Hz electromagnetic field and doxorubicin on Walker-256 carcinosarcoma growth and hepatic redox state in rats.
Research
RF Safe Research Library
Jan 1, 2021
This animal study compared 50 Hz extremely low-frequency EMF exposure with doxorubicin (and their combination) in Walker-256 carcinosarcoma-bearing rats, assessing tumor growth and liver redox-related outcomes. DOX and DOX+EMF were reported to inhibit tumor growth more than EMF alone, though EMF alone also showed an…